Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7806 | 1247 | 50.9 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | 15D PGJ2 | Author keyword | 14 | 32% | 3% | 36 |
2 | 15 DEOXY DELTA12 14 PROSTAGLANDIN J2 | Author keyword | 8 | 29% | 2% | 23 |
3 | PPAR RESEARCH | Journal | 5 | 11% | 4% | 46 |
4 | GW9662 | Author keyword | 5 | 34% | 1% | 12 |
5 | CIGLITAZONE | Author keyword | 4 | 23% | 1% | 14 |
6 | GW1929 | Author keyword | 3 | 60% | 0% | 3 |
7 | EXPT MED NEPHROL | Address | 3 | 22% | 1% | 10 |
8 | 2 CYANO 3 12 DIOXOOLEAN 1 9 DIEN 28 OIC ACID | Author keyword | 2 | 67% | 0% | 2 |
9 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Y | Author keyword | 2 | 67% | 0% | 2 |
10 | CENT HOSP 163 ORTHOPED | Address | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 15D PGJ2 | 14 | 32% | 3% | 36 | Search 15D+PGJ2 | Search 15D+PGJ2 |
2 | 15 DEOXY DELTA12 14 PROSTAGLANDIN J2 | 8 | 29% | 2% | 23 | Search 15+DEOXY+DELTA12+14+PROSTAGLANDIN+J2 | Search 15+DEOXY+DELTA12+14+PROSTAGLANDIN+J2 |
3 | GW9662 | 5 | 34% | 1% | 12 | Search GW9662 | Search GW9662 |
4 | CIGLITAZONE | 4 | 23% | 1% | 14 | Search CIGLITAZONE | Search CIGLITAZONE |
5 | GW1929 | 3 | 60% | 0% | 3 | Search GW1929 | Search GW1929 |
6 | 2 CYANO 3 12 DIOXOOLEAN 1 9 DIEN 28 OIC ACID | 2 | 67% | 0% | 2 | Search 2+CYANO+3+12+DIOXOOLEAN+1+9+DIEN+28+OIC+ACID | Search 2+CYANO+3+12+DIOXOOLEAN+1+9+DIEN+28+OIC+ACID |
7 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Y | 2 | 67% | 0% | 2 | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+Y | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+Y |
8 | DPGJ2 | 1 | 100% | 0% | 2 | Search DPGJ2 | Search DPGJ2 |
9 | PPAR ALPHA KO MICE | 1 | 100% | 0% | 2 | Search PPAR+ALPHA+KO+MICE | Search PPAR+ALPHA+KO+MICE |
10 | PROSTAGLANDIN J2 | 1 | 18% | 0% | 6 | Search PROSTAGLANDIN+J2 | Search PROSTAGLANDIN+J2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 15 DEOXY DELTA12 14 PROSTAGLANDIN J2 | 82 | 30% | 18% | 229 |
2 | 15D PROSTAGLANDIN J2 | 18 | 67% | 1% | 16 |
3 | INHIBIT INFLAMMATORY RESPONSES | 9 | 59% | 1% | 10 |
4 | CYCLOPENTENONE PROSTAGLANDINS | 9 | 14% | 5% | 59 |
5 | PROSTAGLANDIN J2 | 7 | 40% | 1% | 14 |
6 | PPAR GAMMA AGONISTS | 7 | 17% | 3% | 35 |
7 | TRANSIENT FOCAL ISCHEMIA | 6 | 12% | 4% | 47 |
8 | AGONIST PIOGLITAZONE | 6 | 41% | 1% | 11 |
9 | MACROPHAGE GENE EXPRESSION | 5 | 19% | 2% | 23 |
10 | GAMMA AGONISTS | 5 | 17% | 2% | 25 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PPAR RESEARCH | 5 | 11% | 4% | 46 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: Increasing glutamate uptake with PPAR gamma agonists | 2015 | 2 | 114 | 19% |
PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation | 2011 | 101 | 142 | 38% |
Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms | 2007 | 253 | 80 | 45% |
15-Deoxy-Delta(12,14)-prostaglandin J(2), an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling | 2011 | 47 | 127 | 46% |
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists | 2008 | 128 | 118 | 34% |
The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases | 2012 | 21 | 69 | 51% |
PPARs and molecular mechanisms of transrepression | 2007 | 175 | 110 | 35% |
Modulating Microglia Activity with PPAR-gamma Agonists: A Promising Therapy for Parkinson's Disease? | 2013 | 15 | 119 | 35% |
PPARs in the brain | 2007 | 133 | 172 | 37% |
Peroxisome proliferator-activated receptors and inflammation | 2006 | 166 | 155 | 37% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPT MED NEPHROL | 3 | 22% | 0.8% | 10 |
2 | CENT HOSP 163 ORTHOPED | 1 | 100% | 0.2% | 2 |
3 | INFLAMMAT ENVIRONM ASTHME EA3771 | 1 | 100% | 0.2% | 2 |
4 | BIOPATHOL MOL BIOL | 1 | 18% | 0.5% | 6 |
5 | MED EXPT NEPHROL CRIT CARE | 1 | 40% | 0.2% | 2 |
6 | BIOCHEM PATHOBIOCHEM 1 | 1 | 21% | 0.3% | 4 |
7 | EXPT MED NEPHROL CRIT CARE | 1 | 12% | 0.6% | 7 |
8 | UR 545 | 1 | 15% | 0.4% | 5 |
9 | ANESTHESIOL PREOPERAT PAIN MED | 1 | 50% | 0.1% | 1 |
10 | ANESZTEZIOL INTENS TER IAS KLIN | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000276139 | PPAR GAMMA//PPAR RESEARCH//TROGLITAZONE |
2 | 0.0000203962 | PPAR DELTA//PPAR BETA DELTA//PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA |
3 | 0.0000162678 | CYCLOPENTENONE PROSTAGLANDINS//DELTA12 PROSTAGLANDIN J2//DELTA 12 PROSTAGLANDIN J2 |
4 | 0.0000159334 | PIOGLITAZONE//ROSIGLITAZONE//THIAZOLIDINEDIONES |
5 | 0.0000151996 | PRO12ALA POLYMORPHISM//PRO12ALA//PPAR GAMMA 2 |
6 | 0.0000084338 | NITRO FATTY ACIDS//NITRATED FATTY ACIDS//NITRATED LIPIDS |
7 | 0.0000058309 | TROGLITAZONE//JTT 501//CAS 97322 87 7 |
8 | 0.0000056288 | LIVER X RECEPTOR//LXR//LIVER X RECEPTORS |
9 | 0.0000043738 | CRTH2//MOL BEHAV BIOL//PROSTAGLANDIN D 2 |
10 | 0.0000043548 | NEUROINFLAMMAT S//MOL NEUROSCI UNIT//BUTAPROST |